| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8733645 | Critical Reviews in Oncology/Hematology | 2018 | 34 Pages |
Abstract
Tumor heterogeneity strongly affects the molecular mechanisms driving resistance to hormonal therapies in castration-resistant prostate cancer. Since the current use of available treatments can be optimized on the basis of the molecular profile of tumor, the present review focuses on genetic biomarkers in prostate cancer and their application to a personalized treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Marzia Del Re, Stefania Crucitta, Giuliana Restante, Eleonora Rofi, Elena Arrigoni, Elisa Biasco, Andrea Sbrana, Erika Coppi, Luca Galli, Sergio Bracarda, Daniele Santini, Romano Danesi,